Literature DB >> 132915

Bromocriptine in Huntington chorea.

R Kartzinel, R D Hunt, D B Calne.   

Abstract

Following a recent report that apomorphine hydrochloride alleviates the involuntary movements of Huntington chorea, we have investigated another dopamine receptor agonist, bromocriptine, in this disease. A double-blind crossover study in six patients showed that rather than improving chorea, bromocriptine induced an exacerbation. This finding supports the view that choreatic movements correlate with overactivity in dopaminergic systems.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 132915     DOI: 10.1001/archneur.1976.00500070059012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

1.  Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.

Authors:  R J Chalmers; R H Johnson; H J Keogh; R N Nanda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-02       Impact factor: 10.154

Review 2.  The corticostriatal pathway in Huntington's disease.

Authors:  Carlos Cepeda; Nanping Wu; Véronique M André; Damian M Cummings; Michael S Levine
Journal:  Prog Neurobiol       Date:  2006-12-13       Impact factor: 11.685

3.  Effects of DA agonist in Huntington disease hyperkinesia.

Authors:  T A Caraceni; F Girotti; P Giovannini; M Pederzoli; E A Parati
Journal:  Ital J Neurol Sci       Date:  1980-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.